HHS Small Business Innovation Research (SBIR) Program Contract Solicitation (PHS 2019-1) Now Available
Jul 18 2018
HHS Small Business Innovation Research SBIR) Program Contract Solicitation PHS 2019-1) Available Notice Number: NOT-OD-18-209 Key Dates Release Date: July 18, 2018 Related Announcements None Issued National Institutes Health NIH) Centers Disease Control Prevention CDC) Purpose Innovative technologies methodologies fuel progress biomedical behavioral research represent increasingly important area the economy. Small Business Innovation Research SBIR) program provides support research development R&D) new improved technologies methodologies have potential succeed commercial products. purpose this notice to 1) announce issuance the Solicitation the National Institutes Health the Centers Disease Control Prevention Small Business Innovation Research Contract Proposals PHS 2019-1) a receipt date October 22, 2018, 5:00PM EDT; 2) inform public the opportunities the SBIR program offers small business concerns well to scientists research institutions. SBIR legislation requires Public Health Service PHS), Department Health Human Services, certain Federal agencies reserve 3.2 percent FY 2018) their extramural research R&D budgets an SBIR program. NIH SBIR set-aside requirement FY 2018 941 million.) offeror organization must a small business concern defined the Small Business Administration described the Contract Solicitation. primary employment the principal investigator MUST with small business concern the time award during conduct the proposed project. accord the intent the SBIR program increase private sector commercialization innovations derived Federal R&D, scientists research institutions play important role an SBIR project serving consultants and/or subcontractors the small business concern. Generally, to 1/3 the Phase budget be spent consultant and/or subcontractual costs, and, generally, to 1/2 the Phase II budget be spent such costs. this manner, small business concern limited expertise and/or research facilities benefit teaming a scientist(s) a research institution; the scientist(s) a research institution, team effort provides support R&D otherwise obtained. SBIR program consists the following three phases: PHASE I: The objective this phase to determine scientific technical merit feasibility potential commercialization the proposed research R&D efforts the quality performance the small business concern, before consideration further Federal support Phase II. Generally, Phase SBIR awards not exceed 150,000 direct costs, Facilities Administrative F&A) costs, negotiated fixed fee a period generally to exceed six months. PHASE II: The objective this phase to continue research R&D efforts initiated Phase I. Funding shall based the results Phase and scientific technical merit commercial potential the Phase II proposal. Phase contractors eligible apply Phase II grant contract funding will informed Phase II opportunities. However, Fast-Track" Initiative Direct Phase II" below.) Generally, Phase II awards not exceed 1,000,000 direct costs, F&A costs, negotiated fixed fee a period generally to exceed years. PHASE III: The objective this phase for small business concern pursue, non-SBIR funds, commercialization the results the research R&D funded Phases and II. FAST-TRACK": (Applicable only proposals submitted the NIH only an awarding component indicates it accepting Fast-Track proposals a particular topic.) Fast-Track initiative an opportunity small business concerns submit both Phase and Phase II proposal concurrent peer review. initiative also the potential minimize any funding gap between Phase and Phase II. Proposals must prepared accordance Phase and Phase II proposal preparation instructions. DIRECT PHASE II: The congressional authority SBIR Direct Phase II expired. Accordingly Direct Phase II proposals WILL NOT be accepted this soliciation. Submission Process: Offerors responsible submitting proposals, including any revisions modifications the electronic Contract Proposal Submission eCPS) website at https://ecps.nih.gov/sbirsttr by deadline. Offerers must this electronic transmission method. other method proposal submission permitted. Instructions electronic submission provided the solicitation. Pre-proposal webinar: HHS hold pre-proposal conference, via webinar, August 16, 2018 2:00 PM Eastern Daylight Time. informational webinar discuss PHS 2019-1 solicitation, in particular discuss new electronic contract proposal submission eCPS) website. this solicitation, proposals only accepted via eCPS website. Offerors register the webinar at: HHS SBIR PHS 2019-1 Contract Webinar Please register for HHS SBIR PHS 2019-1 Contract Webinar on Aug 16, 2018 2:00 PM EDT at: https://attendee.gotowebinar.com/register/4384275519409493762 After registering, will receive confirmation email containing information joining webinar. Following registration, confirmation e-mail be sent containing information joining webinar. Presentation material this webinar shall posted FedBizOpps the NIH SBIR/STTR webpage following completion. Following the research topics contained the PHS 2019-1 Solicitation: National Institutes Health NIH) National Center Advancing Translational Sciences NCATS) 016 Synthetic Technologies Advancement Research Therapeutics START) 017 Universal Medium/Blood Mimetic Use Integrated Organs-on-Chips 018 Non-PDMS Biocompatible Alternatives Organs-On-Chips National Cancer Institute NCI) 382 Integrated Subcellular Microscopy Omics Cancer Cell Biology 383 Smart, Multi-Core Biopsy Needle 384 Digital Healthcare Platform Reduce Financial Hardship Cancer Patients 385 Leveraging Connected Health Technologies Address Improve Health Outcomes Long Term Cancer Survivors 386 Novel Approaches Local Delivery Chemopreventive Agents 387 Multiplexed Preclinical Tools Longitudinal Characterization Immunological Status Tumor its Microenvironment 388 vitro Diagnostic the Liver Flukes Opisthorchis viverrini Clonorchis sinensis 389 Development Artificial Intelligence AI) Tools Understand Duplicate Experts’ Radiation Therapy Planning Prostate Cancer 390 Clonogenic High-Throughput Assay Screening Anti-Cancer Agents Radiation Modulators 391 Drugs Devices Exploit Immune Response Generated Radiation Therapy 392 Clinical Trials Systemic Targeted Radionuclide Therapies 393 Sensing Tools Measure Biological Response Radiotherapy 394 Combinatory Treatment Modalities Utilizing Radiation Locally Activate Release Systemically Delivered Therapeutics 395 Targeted Therapy Cancer- Cancer Therapy-Related Cachexia 396 Imaging Cancer Immunotherapies National Heart, Lung Blood Institute NHLBI) 106 Active MRI Needle 107 Transcatheter Potts Shunt 108 Device System Transcatheter Repair Postinfarction Ventricular Septal Defect National Institute Alcohol Abuse Alcoholism NIAAA)) 016 Wearable Alcohol Biosensor Quantifies Blood Alcohol Concentration Real Time 017 Data Science Tools Alcohol Research National Institute Allergy Infectious Diseases NIAID) 063 Vivo Targeted Degradation HIV Proteins 064 Particle-Based Delivery HIV Env Immunogens 065 Co-Delivery Formulation Adjuvants HIV Vaccines 066 Effective Targeted Delivery RNA-based Vaccines Therapeutics 067 Methods Improving HIV Protein Expression: Cell Substrate Protein Purification 068 Reagents Immunologic Analysis Non-mammalian Underrepresented Mammalian Models 069 B Cell Receptor T Cell Receptor Repertoire Computational Tools 070 Development Sample Sparing Assay 071 Adjuvant Discovery Vaccines for Autoimmune Allergic Diseases 072 Adjuvant Development Vaccines for Autoimmune Allergic Diseases 073 Mobile Health Point-of-Care Diagnostics 074 Development POC Assays Quantify anti-Tuberculosis Antibiotics Blood 075 POC Diagnostic Gonorrhea Determination Antimicrobial Susceptibility National Institute Drug Abuse NIDA) 165 DEA-Compliant Drug Detection Deactivation Technology Deter Opioid Theft Hospitals Next Generation Controlled Substance Diversion Prevention Program CSDPP) 166 Leveraging Health Solutions Combat Opioid Misuse Centers Disease Control Prevention CDC) Center Global Health CGH) 010 Multiplex Detection Recent Prior Exposure Pathogens 011 Preservation Supply Quality During Unmanned Aerial Vehicle UAV) Transport National Center Chronic Disease Health Promotion NCCDPHP) 041 Community Based Worksite Wellness App Linking Employees Wellness Resources 042 Objective Measurement Opioid Withdrawal Newborns National Center Emerging Zoonotic Infectious Diseases NCEZID) 020 Novel Coatings/Surfaces Indwelling Medical Devices Prevent Biofilms National Center Environmental Health NCEH) 01 Rapid Field Test Improve Swimming Pool Water/Air Quality Office Public Health Preparedness Response OPHPR) 03 Rapid Test Simultaneous Detection Influenza types and B) Streptococcus Group A) Inquiries Please direct inquiries to: Eligibility requirements, definitions, submission procedures, review considerations, contract proposal forms instructions, other pertinent information, including Fast-Track" Initiative, contained the Solicitation PHS 2019-1). Solicitation, including contract proposal forms, available electronically through NIH Small Business Research Funding Opportunities” Web site. SBIR Phase Contract Solicitation PHS 2019-1 PDF http://grants.nih.gov/grants/funding/SBIRContract/PHS2019-1.pdf] MS http://grants.nih.gov/grants/funding/SBIRContract/PHS2019-1.docx]). sure use appropriate CONTRACT PROPOSAL forms they differ the SF424 R&R) GRANT application forms. Note: SBIR Contract Solicitation available ONLY via electronic means. Potential offerors encouraged check the NIH Small Business Research Funding Opportunities Web site updates the program. Any updates corrections the Solicitation be posted there. Contracting Officers Any small business concern intends submit SBIR contract proposal under Solicitation should provide appropriate contracting officer(s) early, written notice its intent, giving name, address, e-mail, telephone, topic number(s). a topic modified canceled before Solicitation closes, only those companies have expressed such intent be notified. National Institutes Health NIH) National Center Advancing Translational Sciences NCATS) Jeffrey Schmidt Contracting Officer NIDA Office Acquisition Phone: 301) 402-1488 Email: firstname.lastname@example.org National Cancer Institute NCI) Tiffany Chadwick Procurement Analyst & Contract Officer Office Acquisitions National Cancer Institute Phone: 240-276-7293 E-mail: email@example.com National Heart, Lung, Blood Institute NHLBI) Joanna Magginas Deputy Director, OA, OM, NHLBI Phone: 301) 827-7740 E-mail: firstname.lastname@example.org National Institute Alcohol Abuse Alcoholism NIAAA) Jeremy White Contracting Officer Branch Chief, NIAAA Branch NICHD Office Acquisitions National Institutes Health, DHHS Phone: 301) 402-4572 Email: email@example.com National Institute Allergy Infectious Diseases NIAID) Charles H. Jackson, Jr. Team Lead, Microbiology Infectious Diseases Research Contracts Branch-A MIDRCB-A) Office Acquisitions, DEA, NIAID Phone: 240) 669-5175 Email: Charles.Jackson@.nih.gov National Institute Drug Abuse NIDA) Kenneth Janosko Contracting Officer Office Acquisition, NIDA Phone: 301) 443-6677 Fax: 301) 443-7595 E-mail: firstname.lastname@example.org Centers Disease Control Prevention CDC) general administrative SBIR program questions, contact: Sean David Griffiths, M.P.H. Office Technology Innovation Office the Associate Director Science Phone: 404-639-4641 Fax: 404-639-4903 E-mail: SBIR@cdc.gov Gwen Barnett, M.P.H. Deputy Director Office Technology Innovation Office the Associate Director Science Phone: 404-639-4791 Fax: 404-639-4903 Email: SBIR@cdc.gov Center Global Health CGH) Theresa Routh-Murphy Contracting Officer Centers Disease Control Prevention Office Financial Resources Phone: 770) 488-2713 Fax: 770) 488-2778 Email: TRouthMurphy@cdc.gov National Center Chronic Disease Health Promotion NCCDPHP) Julio Lopez Contracting Officer Centers Disease Control Prevention Office Financial Resources Phone: 770) 488-2892 Fax: 770) 488-2044 E-mail: JLopez3@cdc.gov National Center Emerging Zoonotic Infectious Diseases NCEZID) Priscilla Turner Contracting Officer Centers Disease Control Prevention Office Financial Resources Phone: 770) 488-2821 Fax: 770) 488-2024 E-mail: PBTurner@cdc.gov National Center Environmental Health NCEH) Vallerie Redd Contracting Officer Center Disease Control Prevention Office Financial Resources Phone: 770) 488-2845 Fax: 770) 488-2847 E-mail: GFJ3@cdc.gov Office Public Health Preparedness Response OPHPR) Christine Godfrey Contracting Officer Centers Disease Control Prevention Office Financial Resources Phone: 770) 488-2519 Fax: 770) 488-2024 E-mail: CNP9@cdc.gov Those interested the PHS small business research GRANT programs, where investigator-initiated research ideas encouraged, invited access the Omnibus Solicitation the Public Health Service Small Business Innovation Research SBIR) Small Business Technology Transfer STTR) Grant Applications PHS 2018-2). understand better differences between grants contracts, see https://sbir.nih.gov/apply.